Now showing items 1-5 of 5

    • Hernández, María Isabel; Martínez Aguayo, Alejandro; Cavada Chacón, Gabriel; Peña Novoa, Verónica; Trejo, León; Ávila, Alejandra; Salazar Cornejo, Teresa; Asenjo, Sylvia; Iñíguez Vila, Germán; Rey, Rodolfo; Mericq, Verónica (De Gruyter, 2013)
      Aim: To compare pubertal development in age-matched healthy girls born with low birth weight (LBW) or appropriate birth weight for gestational age (AGA). Subjects and methods: Girls with breast in Tanner stage II and ...
    • Aros Aránguiz, Sofía Daniela; Mills, James L.; Iñíguez Vila, Germán; Ávila, Alejandra; Conley, Mary R.; Troendle, James; Cox, Christopher; Cassorla Goluboff, Fernando (KARGER, 2011)
      Aims:To study the effect of in-utero alcohol exposure on the insulin-like growth factor axis (IGF) and leptin during infancy and childhood, considering that exposed children may exhibit pre- and postnatal growth retardation. ...
    • Martínez Aguayo, Alejandro; Hernández Cárdenas, María Isabel; Capurro Spadaro, María Teresa; Peña Novoa, Verónica; Ávila, Alejandra; Salazar, T.; Asenjo, S.; Iñíguez Vila, Germán; Mericq, Verónica (Blackwell, 2010)
      Objective To assess normative data and the usefulness of spontaneous and LHRH analogue-stimulated serum LH and FSH levels measured by immunoradiometric assays (IRMA) in the evaluation of normal puberty. Design Prospective. ...
    • Hernández Cárdenas, María Isabel; Martínez Aguayo, Alejandro; Cavada Chacón, Gabriel; Ávila, Alejandra; Iñíguez Vila, Germán; Mericq, Verónica (Wiley & Sons, 2015)
      BackgroundA physiological increase in androgen levels occurs during adolescence. Measuring androgen concentrations is the best method to distinguish normal evolution processes from hyperandrogenic disorders. HypothesisThe ...
    • Martínez-Aguayo,; Hernández Hernández, Felipe; Araneda Beas, Edith; Iñíguez Vila, Germán; Ávila, Alejandra; Sovino,; Bravo, Roberto; Cassorla Goluboff, Fernando (Freund Publishing House Ltd, 2006)
      A new triptorelin 11.25 mg long depot formulation is now available for the treatment of central precocious puberty (CPP). The aim of our study was to evaluate the efficacy of triptorelin 11.25 mg administered every 90 days ...